Columbia Wanger Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-402,500
| Closed | -$42M | – | 204 |
|
|
2015
Q1 | $42M | Sell |
402,500
-75,200
| -16% | -$7.85M | 0.23% | 153 |
|
|
2014
Q4 | $46.3M | Sell |
477,700
-76,300
| -14% | -$7.4M | 0.23% | 147 |
|
|
2014
Q3 | $43.3M | Sell |
554,000
-230,500
| -29% | -$18M | 0.2% | 168 |
|
|
2014
Q2 | $49.6M | Sell |
784,500
-118,264
| -13% | -$7.47M | 0.2% | 170 |
|
|
2014
Q1 | $60.6M | Sell |
902,764
-1,007,236
| -53% | -$67.6M | 0.24% | 145 |
|
|
2013
Q4 | $123M | Buy |
1,910,000
+595,144
| +45% | +$38.3M | 0.47% | 66 |
|
|
2013
Q3 | $84.2M | Buy |
1,314,856
+216,856
| +20% | +$13.9M | 0.34% | 103 |
|
|
2013
Q2 | $34M | Buy |
+1,098,000
| New | +$34M | 0.15% | 202 |
|